PROFOUND MEDICAL CORP.
Income Statement
| Line Item | Jun 2024 | Mar 2024 |
|---|---|---|
| Revenue | $2.2M | $1.4M |
| Cost of Revenue | $812.0K | $573.0K |
| Gross Profit | $1.4M | $866.0K |
| Gross Margin | 63.6% | 60.2% |
| Operating Expenses | ||
| Research & Development | $4.2M | $3.9M |
| SG&A Expense | $5.1M | $4.8M |
| Operating Income | $-7.8M | $-7.9M |
| Operating Margin | -351.2% | -547.4% |
| Interest Expense | — | — |
| Pretax Income | $-6.9M | $-6.5M |
| Income Tax Expense | $19.0K | $40.0K |
| Net Income | $-6.9M | $-6.6M |
| Net Margin | -309.9% | -457.6% |
| EPS (Basic) | $0.28 | $0.27 |
| EPS (Diluted) | $0.28 | $0.27 |
| Shares Outstanding (Basic) | 24.4M | 24.3M |
| Shares Outstanding (Diluted) | 24.4M | 24.3M |
| Dividends Per Share | — | — |